Eine internationale Allianz gibt Gelder für das US-Unternehmen, das während der Coronapandemie einen Impfstoff in Rekordzeit entwickelt hat.
Loading…
MODERATETagesspiegelUnverifiedNo Trust Score IssuedUnpublished
Moderna develops mRNA vaccine against Ebola
ebolamodernavaccine-developmentpublic-healthbundibugyo-variant
Moderna is developing an mRNA vaccine against the Bundibugyo variant of Ebola, backed by an international alliance. The company had previously developed a vaccine in record time during the coronavirus pandemic.